Cyrus' plan for quick LL approval (simple suggesti
Post# of 148331
(Total Views: 672)
Posted On: 09/15/2022 1:28:46 PM
Cyrus' plan for quick LL approval (simple suggestion)
column 1: Leronlimab specific indication name
column 2: 1-10 where 1 is most likely FDA will approve, with consideration there would be liitle reason to "slow walk" an approval
column 3: The cost of obtaining the approval
column 4: Estimated number of months to obtain approval
column 5: number of trial participants - this is in addition to column 3 because more can go wrong if the number of participants required is high (harder to manage)
Cyrus, pick one indication that has the fewest weighted points. The purpose is to obtain our first approval quickly so we can hedge against a very, very long delay in obtaining the approvals we really want/need/prefer.
Identify to stockholders which indication you picked and call it the "bbqbbq" initiative. "BBQ so nice they named it twice."
column 1: Leronlimab specific indication name
column 2: 1-10 where 1 is most likely FDA will approve, with consideration there would be liitle reason to "slow walk" an approval
column 3: The cost of obtaining the approval
column 4: Estimated number of months to obtain approval
column 5: number of trial participants - this is in addition to column 3 because more can go wrong if the number of participants required is high (harder to manage)
Cyrus, pick one indication that has the fewest weighted points. The purpose is to obtain our first approval quickly so we can hedge against a very, very long delay in obtaining the approvals we really want/need/prefer.
Identify to stockholders which indication you picked and call it the "bbqbbq" initiative. "BBQ so nice they named it twice."
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼